ProKidney Corp
Change company Symbol lookup
Select an option...
PROK ProKidney Corp
HUN Huntsman Corp
IART Integra Lifesciences Holdings Corp
R Ryder System Inc
AAPL Apple Inc
IIM Invesco Value Municipal Income Trust
QQQ Invesco QQQ Trust
VZ Verizon Communications Inc
CHTR Charter Communications Inc
SPB Spectrum Brands Holdings Inc
Go

Company profile

ProKidney Corp., formerly Social Capital Suvretta Holdings Corp. III, is a clinical-stage biotechnology company. The Company is focused on developing a cell therapy platform capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. Its lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to stabilize or improve kidney function in a CKD patient's diseased kidneys. REACT is a product that includes selected renal cells (SRCs) prepared from a patient’s own, autologous, renal cells. The Company is focused on conducting a Phase III development program and multiple Phase II clinical trials for REACT in subjects with moderate to severe diabetic kidney disease.

The symbol you entered, DNAC, changed to PROK.

Price
Delayed
$7.67
Day's Change
-0.295 (-3.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.96
Day's Low
7.17
Volume
(Light)

Today's volume of 4,771 shares is on pace to be much lighter than PROK's 10-day average volume of 34,571 shares.

4,771
  • Prev Close
    7.96
  • Today's Open
    7.96
  • Day's Range
    7.17-7.96
  • Avg Vol (10-day)
    34.6K
  • Last (time)
    3:32p ET 08/15/22
  • Last (size)
    100
  • 52-Wk Range
    6.19 - 11.98
    LowHigh
  • (07/27/22 - 08/09/22)
    23.83%
  • 45.9%
  • Market Cap
    441.9M
  • Shares Outstanding
    61.5M
  • -0.19
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 25.22
  • (% of float 07/29/22)
    1.29

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.